While chemists were concluding that the controversial cancer drug Krebiozen is nothing but the common body chemical, creatine, a committee of 24 medical experts was checking the histories of 504 patients who were said to have benefited from the drug. Last week the committee reported unanimously that Krebiozen is ineffective. The National Cancer Institute said there will be no government-sponsored trial of Krebiozen—the case is closed.
...
To continue reading:
or
Log-In
